Bhugan Lifescience Profile
Key Indicators
- Authorised Capital ₹ 5.21 Cr
as on 23-10-2024
- Paid Up Capital ₹ 5.21 Cr
as on 23-10-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.18 Cr
as on 23-10-2024
- Satisfied Charges ₹ 2.75 Cr
as on 23-10-2024
- Revenue 1147.10%
(FY 2023)
- Profit 100.06%
(FY 2023)
- Ebitda 373.20%
(FY 2023)
- Net Worth 112.35%
(FY 2023)
- Total Assets 71.22%
(FY 2023)
About Bhugan Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.21 Cr and a paid-up capital of Rs 5.21 Cr.
The company currently has active open charges totaling ₹20.18 Cr. The company has closed loans amounting to ₹2.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pranjal Ganeshbhai and Manishkumar Patel serve as directors at the Company.
- CIN/LLPIN
U24230GJ2019PTC110648
- Company No.
110648
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bhugan Lifescience?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranjal Ganeshbhai  | Director | 04-Nov-2019 | Current |
| Manishkumar Patel | Director | 04-Nov-2019 | Current |
Financial Performance of Bhugan Lifescience.
Bhugan Lifescience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1147.1% increase. The company also saw a substantial improvement in profitability, with a 100.06% increase in profit. The company's net worth Soared by an impressive increase of 112.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhugan Lifescience?
In 2023, Bhugan Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bhugan Infracon Private LimitedActive 11 years 2 monthsPranjal Ganeshbhai and Manishkumar Patel are mutual person
Bhugan Films Private LimitedActive 4 years 5 monthsPranjal Ganeshbhai and Manishkumar Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 31 Jan 2022 | ₹1.47 Cr | Open |
Canara Bank Creation Date: 30 Oct 2021 | ₹9.96 Cr | Open |
Sidbi Creation Date: 09 Feb 2021 | ₹8.75 Cr | Open |
How Many Employees Work at Bhugan Lifescience?
Bhugan Lifescience has a workforce of 21 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhugan Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhugan Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
